Risk factors for the development of lithium-induced polyuria

British Journal of Psychiatry

Volumn 182, Issue APR., 2003, Pages 319-323

  Movig, K L L ^a   Baumgarten, R ^c   Leufkens, H G M ^b   Van Laarhoven, J H M ^d   Egberts, A C G ^a,b  

^a GGZ Midden Brabant   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c Sittard Geleen Heerlen   (Netherlands)

^d CPRLab   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM; SEROTONIN AGONIST;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; POLYURIA; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; URINALYSIS; URINE VOLUME;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LITHIUM; MALE; MIDDLE AGED; POLYURIA; PROSPECTIVE STUDIES; RISK FACTORS; SEROTONIN AGENTS; TREATMENT OUTCOME;

EID: 0344838538     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.182.4.319     Document Type: Article

References (20)

1. Allon, M., Allen, H., Deck, L., et al (1990) Role of cigarette use in hyponatremia in schizophrenic patients. American Journal of Psychiatry, 147, 1075-1077.
2. Baumgarten, R., van de Pol, M. H., Deen, P. M., et al (2000) Dissociation between urine osmolality and urinary excretion of aquaporin-2 in healthy volunteers. Nephrology, Dialysis, Transplantation, 15, 1155-1161.
3. Baylis, P. H. (1996) Water and sodium homeostasis and their disorders. In Oxford Textbook of Medicine (eds D. J. Weatherall, J. G. G. Ledingham & D. A. Warrel). pp. 3116-3126. Oxford: Oxford University Press.
4. Bendz, H., Andersch, S. & Aurell, M. (1983) Kidney function in an unselected lithium population. A cross-sectional study. Acta Psychiatrica Scandinavica, 68, 325-334.
5. _, Aurell, M., Balldin, J., et al (1994) Kidney damage in long-term lithium patients: a cross-sectional study of patients with 15 years or more on lithium. Nephrology, Dialysis, Transplantation, 9, 1250-1254.
6. Bone, S., Roose, S. P., Dunner, D. L., et al (1980) Incidence of side effects in patients on long-term lithium therapy. American Journal of Psychiatry, 137, 103-104.
7. Boton, R., Gaviria, M. & Battle, D. C. (1987) Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. American Journal of Kidney Disease, 10, 329-345.
8. Bowen, R. C., Grof, P. & Grof, E. (1991) Less frequent lithium administration and lower urine volume. American Journal of Psychiatry, 148, 189-192.
9. Deen, P. M. & Knoers, N. V. (1998) Physiology and pathophysiology of the aquaporin-2 water channel. Current Opinion in Nephrology and Hypertension, 7, 37-42.
10. Fava, M., Rosenbaum, J. F., McGrath, P. J., et al (1994) Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study. American Journal of Psychiatry, 151, 1372-1374.
11. Maj, M., Starace, F., Nolfe, G., et al (1986) Minimum plasma lithium levels required for effective prophylaxis in DSM III bipolar disorder: a prospective study. Pharmacopsychiatry, 19, 420-423.
12. Marples, D., Christensen, S., Christensen, E. I., et al (1995) Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. Journal of Clinical Investigation, 95, 1838-1845.
13. Martin, A. (1993) Clinical management of lithium-induced polyuria. Hospital and Community Psychiatry, 44, 427-428.
14. Mitchell, P. B. (1997) Drug interactions of clinical significance with selective serotonin reuptake inhibitors. Drug Safety, 17, 390-406.
15. Movig, K. L. L., Egberts, A. C. G., Lenderink, A. W., et al (2002) Association between antidepressant drugs and hyponatremia: a case-control study. British Journal of Clinical Pharmacology, 53, 363-369.
16. Muller-Oerlinghausen, B., Berghofer, A. & Bauer, M. (2002) Bipolar disorder. Lancet, 359, 241-247.
17. O'Donovan, C., Hawkes, J. & Bowen, R. (1993) Effect of lithium dosing schedule on urinary output. Acta Psychiatrica Scandinavica, 87, 92-95.
18. Stahl, S. M. (1998) Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. Journal of Affective Disorders, 51, 215-235.
19. Tatsumi, M., Groshan, K., Blakely, R. D., et al (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. European Journal of Pharmacology, 340, 249-258.
20. Zullino, D. & Baumann, P. (2001) Lithium augmentation in depressive patients not responding to selective serotonin reuptake inhibitors. Pharmacopsychiatry, 34, 119-127.